Biotech · Private company
Prometic Biotherapeutics, Inc.
Track this companyFree. Adds Prometic Biotherapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- Immune Globulin IntravenousPhase 3 · Primary ImmunodeficiencyClinicalTrials.gov · fetched Nov 12, 2026
- Plasminogen (Human) intravenousPhase 3 · HypoplasminogenemiaClinicalTrials.gov · fetched Nov 12, 2026
- Prometic's Immune Globulin Intravenous 10%Phase 3 · Primary ImmunodeficiencyClinicalTrials.gov · fetched Nov 12, 2026
- RyplazimHypoplasminogenemiaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Study of Prometic Plasminogen IV Infusion in Subjects With HypoplasminogenemiaPHASE2_PHASE3 · COMPLETED · started May 4, 2016ClinicalTrials.gov NCT02690714 · fetched Nov 12, 2026
- Study of ProMetic BioTherapeutics Immune Globulin Intravenous (Human) 10%PHASE3 · COMPLETED · started Jan 26, 2016ClinicalTrials.gov NCT02269163 · fetched Nov 12, 2026
- A Treatment Protocol for Expanded Access Administration of Prometic Plasminogen Due to Closure of Clinical TrialNO_LONGER_AVAILABLEClinicalTrials.gov NCT03642691 · fetched Nov 12, 2026